Literature DB >> 17446026

[Campylobacter fetus bacteremia and cellulitis complicating a venous access port infection in an HIV infected patient].

C Rapp1, P Imbert, R Fabre, J D Cavallo, T Debord.   

Abstract

Campylobacter fetus subspecies fetus is an opportunist Gram-negative bacillus, which is known to be a cause of systemic infections, mainly in immunocompromised patients. We report a C. fetus bacteremia and cellulitis complicating a venous access port infection in a patient with acquired immunodeficiency syndrome (AIDS). This bacillus seems to have a predilection for the vascular endothelium and its isolation is difficult. Physicians should be aware of C. fetus infection in patients with vascular devices. Microbiologists should accurately isolate this organism from clinical specimens by modifying incubation techniques and performing molecular biology. The prognosis seems to be improved by a prolonged betalactam antibiotic regimen, especially amoxicilline plus clavulanic acid. In HIV infected patients, quinolones that were successful in our case, should be used with caution because of increasing resistance to antibiotics.

Entities:  

Mesh:

Year:  2007        PMID: 17446026     DOI: 10.1016/j.medmal.2007.02.001

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  3 in total

1.  Campylobacter fetus-associated epidural abscess and bacteremia.

Authors:  Jenny S J Wong; Trevor P Anderson; Stephen T Chambers; Stephen L W On; David R Murdoch
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

Review 2.  HIV and Mediterranean Zoonoses: A Review of the Literature.

Authors:  Ylenia Russotto; Cristina Micali; Giovanni Francesco Pellicanò; Giuseppe Nunnari; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-09-16

3.  Effect of noradrenaline on the virulence properties of campylobacter species.

Authors:  Sree V Aroori; Tristan A Cogan; Tom J Humphrey
Journal:  Int J Microbiol       Date:  2014-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.